Alexandria Real Estate Equities Inks Boston Full-Building Lease to Novo Nordisk

Novo Nordisk will be occupying the entirety of the 165,000-square-foot R&D office property at 60 Sylvan Rd., which is being redeveloped for delivery in 2025.